V. Schirmer

Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin’s lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19)

D. Niederwieser, M. Herold, A. Franke, 2006, Journal of Cancer Research and Clinical Oncology.

Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem‐cell transplantation or conventional chemotherapy: results of a Phase I clinical trial

H. Goldschmidt, D. Niederwieser, R. Rohrberg, 2008, British journal of haematology.